MedTrace Logo

A Prospective Study of the Performance of the Bard® LifeStent® Vascular Stent Systems (REALITY)

NCT01920308 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2016-11-10

No results posted yet for this study

Summary

The purpose of this study is to assess the deliverability, clinical utility and effectiveness of the 5 mm diameter size offering of the LifeStent® Vascular Stent

Conditions

Interventions

DEVICE

5 mm Bard LifeStent Vascular Stent

The LifeStent® Vascular Stent is a peripheral stent intended to improve luminal diameter in the treatment of symptomatic de-novo or restenotic lesions up to 240 mm in length in the native superficial femoral artery (SFA) and popliteal artery with reference vessel diameters ranging from 4.0 - 6.5 mm.

Sponsors & Collaborators

  • C. R. Bard

    lead INDUSTRY

Principal Investigators

  • Thomas Zeller, Prof. Dr. · University Heart Centre in Bad Krozingen

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-04-30
Completion
2015-07-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01920308 on ClinicalTrials.gov